Eyepoint Pharmaceuticals Stock Math Transform Exponential Price Movement

EYPT Stock  USD 13.23  -0.80  -5.70%   
Use the math transform workspace to apply Exponential Price Movement transformation and other studies to Eyepoint Pharmaceuticals. This view tracks price transformations that reveal shifts in trend structure to support structured performance interpretation without implying advice.

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Eyepoint Pharmaceuticals Price Movement is a mathematical transformation function to describe exponentially increasing price patterns.

Eyepoint Pharmaceuticals Technical Analysis Modules

Most technical analysis of Eyepoint Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Eyepoint from various momentum indicators to cycle indicators. When you analyze Eyepoint charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts. Eyepoint Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people. A high-level view of Eyepoint Pharmaceuticals emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Current metrics include P/B of 4.07. Eyepoint Pharmaceuticals has a market cap of 1.17 B, ROE of -72.19%.

Methodology

Unless otherwise specified, financial data for Eyepoint Pharmaceuticals is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Eyepoint (USA Stocks:EYPT) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information presented is compiled from public filings and market reference sources and official institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR. Updates can be delayed depending on reporting conventions. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Eyepoint Pharmaceuticals is covered by 13 analysts. 6 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include J.P. Morgan, Stifel, BMO Capital Markets, Oppenheimer & Co., Citigroup, RBC Capital Markets, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board

Become your own money manager

Tracking Eyepoint Pharmaceuticals inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Money Flow Index Now

   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Blockchain Idea
Blockchain
Invested few shares
Momentum Idea
Momentum
Invested over 20 shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Advertising Idea
Advertising
Invested few shares
Software Idea
Software
Invested few shares
Video Games Idea
Video Games
Invested few shares
Impulse Idea
Impulse
Invested over 200 shares
Hedge Favorites Idea
Hedge Favorites
Invested few shares
Cash Cows Idea
Cash Cows
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested few shares

Additional Tools for Eyepoint Stock Analysis

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data